Study Complete
Sponsor ID
20120334
Study to Assess the Long-term Safety and Efficacy of KAI-4169 (also known as AMG 416) in the Treatment of Chronic Kidney Disease-Mineral and Bone Disorder in Patients with Secondary Hyperparathyroidism.
Study Details
Protocol Summary
Primary Outcome Measures
Not Available
Secondary Outcome Measures
Not Available
Study Documents
Study Synopsis
Available Language(s): English
Locations
Location
Research Site
Denver, CO, United States, 80230
Status
Completed
Location
Research Site
Meridian, ID, United States, 83642
Status
Completed
Location
Research Site
San Antonio, TX, United States, 78215
Status
Completed
Location
Research Site
Philadelphia, PA, United States, 19106
Status
Completed
Location
Research Site
Tempe, AZ, United States, 85284
Status
Completed